Camber Capital Management’s Zimmer Biomet ZBH Stock Holding History

Camber Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$91.2M	Sell	1,000,000 -1,250,000	-56%	-$121M	8.56%	2
2025 Q1	$255M	Buy	2,250,000 +645,000	+40%	+$69M	9.05%	2
2024 Q4	$170M	Sell	1,605,000 -895,000	-36%	-$96M	3.92%	4
2024 Q3	$270M	Buy	2,500,000 +575,000	+30%	+$62.8M	8.57%	2
2024 Q2	$209M	Hold	1,925,000	–	–	5.78%	2
2024 Q1	$254M	Hold	1,925,000	–	–	6.23%	2
2023 Q4	$234M	Buy	1,925,000 +75,000	+4%	+$8.37M	5.97%	4
2023 Q3	$208M	Buy	1,850,000 +800,000	+76%	+$102M	6.84%	4
2023 Q2	$153M	Sell	1,050,000 -200,000	-16%	-$27.2M	4.98%	7
2023 Q1	$162M	Hold	1,250,000	–	–	4.97%	9
2022 Q4	$159M	Sell	1,250,000 -150,000	-11%	-$17.4M	5.47%	7
2022 Q3	$146M	Buy	1,400,000 +50,000	+4%	+$5.49M	4.48%	6
2022 Q2	$142M	Hold	1,350,000	–	–	6.15%	3
2022 Q1	$173M	Buy	1,350,000 +320,000	+31%	+$38.6M	6.25%	4
2021 Q4	$127M	Buy	1,030,000 +283,157	+38%	+$37.1M	4.37%	8
2021 Q3	$106M	Buy	+746,843	New	+$110M	3.27%	11
2021 Q2	–	Sell	-643,750	Closed	-$100M	–	40
2021 Q1	$100M	Buy	+643,750	New	+$99.7M	3.43%	10

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Camber Capital Management's ZBH Position: Q2 2025 in Review

Camber Capital Management reduced its Zimmer Biomet (ZBH) stake by 56% in Q2 2025, selling an estimated $121M and leaving 1,000,000 shares worth $91.2M. The position accounts for 8.56% of the portfolio, ranked #2.

Camber Capital Management first reported a position in ZBH in Q1 2021 and has held it in 17 quarters since. The position peaked at $270M in Q3 2024. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

Camber Capital Management held 1,000,000 shares of Zimmer Biomet worth $91.2M as of Q2 2025.
Camber Capital Management sold 1,250,000 Zimmer Biomet shares in Q2 2025, an estimated $121M.
Zimmer Biomet made up 8.56% of Camber Capital Management's portfolio in Q2 2025, its #2 holding.
Camber Capital Management first reported a position in Zimmer Biomet in Q1 2021 and has held it in 17 quarters since.
Camber Capital Management's Zimmer Biomet position peaked at $270M in Q3 2024.
934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Camber Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.